Breaking News Instant updates and real-time market news.

NVS

Novartis

$83.68 /

-0.4 (-0.48%)

07:45
03/09/21
03/09
07:45
03/09/21
07:45

Novartis reports CANOPY-2 trial did not meet primary endpoint

Novartis announced the Phase III CANOPY-2 study evaluating canakinumab, an inhibitor of interleukin-1beta, in combination with the chemotherapy agent docetaxel, did not meet its primary endpoint of overall survival, or OS. The trial was conducted among 237 adults with locally advanced or metastatic non-small cell lung cancer, or NSCLC, whose disease progressed while on or after previous platinum-based chemotherapy and PD-(L)1 inhibitor immunotherapy. Two Phase III CANOPY trials continue, evaluating canakinumab in first-line and adjuvant settings2,3. Novartis and CANOPY-2 investigators will analyze the study data and are expected to submit its findings for presentation at an upcoming medical meeting. CANOPY-1, a Phase III study evaluating canakinumab in combination with immunotherapy and chemotherapy, is expected to report final results before the end of the year2. CANOPY-A, another Phase III study, is investigating canakinumab as an adjuvant therapy and has enrolled more than 950 patients to date and is expected to enroll a total of 1,500 patients. "While results from the CANOPY-2 trial are not what we hoped for in patients with advanced or metastatic non-small cell lung cancer who have been treated with other lines of therapy, these data give us valuable insights into IL-1beta inhibition," said John Tsai, MD, Head of Global Drug Development and Chief Medical Officer at Novartis. "Ongoing Phase III studies in non-small cell lung cancer continue, evaluating canakinumab in earlier treatment settings. We sincerely thank the patients and clinical investigators involved in the CANOPY-2 study for their partnership."

  • 09

    Mar

NVS Novartis
$83.68 /

-0.4 (-0.48%)

03/01/21 Oppenheimer
Homology Medicines loses potential source of upside, says Oppenheimer
02/02/21 Morgan Stanley
Novartis price target lowered to CHF 102 from CHF 104 at Morgan Stanley
02/01/21 Truist
iRhythm price target lowered to $220 from $265 at Truist
02/01/21 Cowen
Novartis downgraded to Market Perform after 'tepid' guidance at Cowen

TODAY'S FREE FLY STORIES

Hot Stocks
Byrna Technologies: Spokane PD approves weapons purchases » 08:34
12/03/21
12/03
08:34
12/03/21
08:34
BYRN

Byrna Technologies

$13.69 /

-0.72 (-5.00%)

Byrna Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BYRN Byrna Technologies
$13.69 /

-0.72 (-5.00%)

BYRN Byrna Technologies
$13.69 /

-0.72 (-5.00%)

09/10/21 B. Riley
Byrna Technologies price target raised to $36 from $31 at B. Riley
08/20/21
Fly Intel: Top five analyst initiations
08/20/21 Raymond James
Byrna Technologies initiated with a Strong Buy at Raymond James
08/20/21 Raymond James
Byrna Technologies initiated with a Strong Buy at Raymond James
BYRN Byrna Technologies
$13.69 /

-0.72 (-5.00%)

  • 16
    Jul
BYRN Byrna Technologies
$13.69 /

-0.72 (-5.00%)

BYRN Byrna Technologies
$13.69 /

-0.72 (-5.00%)

Hot Stocks
Casey's General Stores appoints Katrina Lindsey chief legal officer » 08:34
12/03/21
12/03
08:34
12/03/21
08:34
CASY

Casey's General Stores

$195.92 /

+4.61 (+2.41%)

, ODP

ODP Corporation

$38.03 /

+1.355 (+3.70%)

Casey's General…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CASY Casey's General Stores
$195.92 /

+4.61 (+2.41%)

ODP ODP Corporation
$38.03 /

+1.355 (+3.70%)

CASY Casey's General Stores
$195.92 /

+4.61 (+2.41%)

12/01/21 RBC Capital
Casey's General Stores price target raised to $246 from $233 at RBC Capital
11/30/21 Deutsche Bank
Casey's General Stores price target raised to $264 from $256 at Deutsche Bank
09/14/21 Northcoast
Casey's General Stores upgraded to Buy from Neutral at Northcoast
09/09/21 Deutsche Bank
Casey's price target raised to $256 from $246 at Deutsche Bank
ODP ODP Corporation
$38.03 /

+1.355 (+3.70%)

02/25/21 UBS
ODP Corporation upgraded to Neutral from Sell at UBS
01/12/21 JPMorgan
ODP Corporation upgraded to Neutral following Staples bid at JPMorgan
01/12/21 JPMorgan
ODP Corporation upgraded to Neutral from Underweight at JPMorgan
CASY Casey's General Stores
$195.92 /

+4.61 (+2.41%)

ODP ODP Corporation
$38.03 /

+1.355 (+3.70%)

CASY Casey's General Stores
$195.92 /

+4.61 (+2.41%)

ODP ODP Corporation
$38.03 /

+1.355 (+3.70%)

Earnings
Gulf Resources sees Q4 revenues $18M-$19M » 08:33
12/03/21
12/03
08:33
12/03/21
08:33
GURE

Gulf Resources

$5.34 /

-0.165 (-3.00%)

The Company's fourth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GURE Gulf Resources
$5.34 /

-0.165 (-3.00%)

GURE Gulf Resources
$5.34 /

-0.165 (-3.00%)

GURE Gulf Resources
$5.34 /

-0.165 (-3.00%)

Hot Stocks
Harbor Custom Development to acquire 997-unit planned community for $14M » 08:33
12/03/21
12/03
08:33
12/03/21
08:33
HCDI

Harbor Custom Development

$2.82 /

-0.005 (-0.18%)

Harbor Custom Development…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCDI Harbor Custom Development
$2.82 /

-0.005 (-0.18%)

HCDI Harbor Custom Development
$2.82 /

-0.005 (-0.18%)

  • 13
    Jan
Technical Analysis
Nasdaq Composite: Pivot points » 08:33
12/03/21
12/03
08:33
12/03/21
08:33
$COMP

Nasdaq Composite

/

+

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

$COMP Nasdaq Composite
/

+

Syndicate
AppLovin 6.5M share Spot Secondary priced at $83.00 » 08:33
12/03/21
12/03
08:33
12/03/21
08:33
APP

AppLovin

$90.37 /

+4.09 (+4.74%)

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APP AppLovin
$90.37 /

+4.09 (+4.74%)

APP AppLovin
$90.37 /

+4.09 (+4.74%)

11/18/21
Fly Intel: Top five analyst initiations
11/18/21 Arete
AppLovin initiated with a Sell at Arete
11/12/21 Stifel
AppLovin price target raised to $125 from $110 at Stifel
11/11/21 Truist
AppLovin price target raised to $110 from $100 at Truist
APP AppLovin
$90.37 /

+4.09 (+4.74%)

  • 03
    Dec
  • 15
    Apr
APP AppLovin
$90.37 /

+4.09 (+4.74%)

Recommendations
Aspen Aerogels price target raised to $67 from $58 at Cowen » 08:33
12/03/21
12/03
08:33
12/03/21
08:33
ASPN

Aspen Aerogels

$53.12 /

-0.81 (-1.50%)

Cowen analyst Jeffrey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASPN Aspen Aerogels
$53.12 /

-0.81 (-1.50%)

ASPN Aspen Aerogels
$53.12 /

-0.81 (-1.50%)

11/22/21 Piper Sandler
Aspen Aerogels price target raised to $72 from $58 at Piper Sandler
10/29/21 B. Riley
Aspen Aerogels price target raised to $60 from $53 at B. Riley
10/29/21 Canaccord
Aspen Aerogels price target raised to $52 from $45 at Canaccord
10/29/21 H.C. Wainwright
Aspen Aerogels price target raised to $65 from $45 at H.C. Wainwright
ASPN Aspen Aerogels
$53.12 /

-0.81 (-1.50%)

Hot Stocks
Revive Therapeutics expands bucillamine research to treat omicron variant » 08:32
12/03/21
12/03
08:32
12/03/21
08:32
RVVTF

Revive Therapeutics

/

+

Revive Therapeutics is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RVVTF Revive Therapeutics
/

+

General news
November nonfarm payrolls up 210,000 vs. last month, consensus 545,000  08:32
12/03/21
12/03
08:32
12/03/21
08:32
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Mullen Automotive begins validation process for Class 2 EV cargo vans » 08:31
12/03/21
12/03
08:31
12/03/21
08:31
MULN

Mullen Automotive

$6.56 /

-0.68 (-9.39%)

Mullen Automotive…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MULN Mullen Automotive
$6.56 /

-0.68 (-9.39%)

Hot Stocks
Sabre, American Express Global Business Travel announce partnership » 08:31
12/03/21
12/03
08:31
12/03/21
08:31
SABR

Sabre

$8.37 /

+0.785 (+10.36%)

, AXP

American Express

$156.67 /

+6.51 (+4.34%)

Sabre (SABR) and American…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SABR Sabre
$8.37 /

+0.785 (+10.36%)

AXP American Express
$156.67 /

+6.51 (+4.34%)

SABR Sabre
$8.37 /

+0.785 (+10.36%)

05/05/21 Mizuho
Sabre price target lowered to $13 from $15 at Mizuho
04/16/21 Mizuho
Sabre price target raised to $15 from $13 at Mizuho
03/29/21 Mizuho
Sabre price target raised to $13 from $11 at Mizuho
03/16/21 Morgan Stanley
Sabre downgraded to Equal Weight at Morgan Stanley following over 50% rally
AXP American Express
$156.67 /

+6.51 (+4.34%)

10/29/21 Citi
Citi upgrades Synchrony to Buy on higher loan growth estiamtes
10/25/21 BMO Capital
American Express price target raised to $151 from $147 at BMO Capital
10/25/21 Deutsche Bank
American Express price target raised to $200 from $190 at Deutsche Bank
10/25/21 Stephens
American Express price target raised to $190 from $180 at Stephens
SABR Sabre
$8.37 /

+0.785 (+10.36%)

AXP American Express
$156.67 /

+6.51 (+4.34%)

AXP American Express
$156.67 /

+6.51 (+4.34%)

AXP American Express
$156.67 /

+6.51 (+4.34%)

SABR Sabre
$8.37 /

+0.785 (+10.36%)

AXP American Express
$156.67 /

+6.51 (+4.34%)

General news
November U.S. nonfarm payrolls rise 210,000, unemployment rate 4.2%  08:30
12/03/21
12/03
08:30
12/03/21
08:30
$ECON

Economic Data

/

+

, SPY

SPDR S&P 500 ETF Trust

$457.40 /

+6.88 (+1.53%)

, SPX

S&P 500

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

SPY SPDR S&P 500 ETF Trust
$457.40 /

+6.88 (+1.53%)

SPX S&P 500
/

+

$ECON Economic Data
/

+

SPY SPDR S&P 500 ETF Trust
$457.40 /

+6.88 (+1.53%)

SPX S&P 500
/

+

$ECON Economic Data
/

+

SPY SPDR S&P 500 ETF Trust
$457.40 /

+6.88 (+1.53%)

SPX S&P 500
/

+

$ECON Economic Data
/

+

SPY SPDR S&P 500 ETF Trust
$457.40 /

+6.88 (+1.53%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$457.40 /

+6.88 (+1.53%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$457.40 /

+6.88 (+1.53%)

SPX S&P 500
/

+

Options
One new option listing on December 3rd » 08:30
12/03/21
12/03
08:30
12/03/21
08:30
CCB

Coastal Financial

$44.90 /

+1.555 (+3.59%)

New option listings for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCB Coastal Financial
$44.90 /

+1.555 (+3.59%)

07/07/21 Stephens
Coastal Financial initiated with an Overweight at Stephens
CCB Coastal Financial
$44.90 /

+1.555 (+3.59%)

Technical Analysis
Nasdaq 100 Index: Pivot points » 08:26
12/03/21
12/03
08:26
12/03/21
08:26
NDX

Nasdaq 100 Index

/

+

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NDX Nasdaq 100 Index
/

+

NDX Nasdaq 100 Index
/

+

Hot Stocks
Capstone Green Energy distributor signs new 10-year FPP, CHP » 08:26
12/03/21
12/03
08:26
12/03/21
08:26
CGRN

Capstone Green Energy

$4.41 /

-0.09 (-2.00%)

Capstone Green Energy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGRN Capstone Green Energy
$4.41 /

-0.09 (-2.00%)

  • 18
    Jun
CGRN Capstone Green Energy
$4.41 /

-0.09 (-2.00%)

Periodicals
FDA planning fast review of omicron vaccines and drugs, WSJ reports » 08:24
12/03/21
12/03
08:24
12/03/21
08:24
MRNA

Moderna

$301.46 /

-9.24 (-2.97%)

, PFE

Pfizer

$53.02 /

-1.65 (-3.02%)

, BNTX

BioNTech

$333.55 /

-1.09 (-0.33%)

, AZN

AstraZeneca

$54.78 /

-0.1 (-0.18%)

, JNJ

Johnson & Johnson

$157.08 /

-1.06 (-0.67%)

, MRK

Merck

$73.89 /

-0.54 (-0.73%)

, LLY

Eli Lilly

$247.84 /

-1.39 (-0.56%)

, REGN

Regeneron

$634.44 /

+2.08 (+0.33%)

The Food and Drug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$301.46 /

-9.24 (-2.97%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

BNTX BioNTech
$333.55 /

-1.09 (-0.33%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

LLY Eli Lilly
$247.84 /

-1.39 (-0.56%)

REGN Regeneron
$634.44 /

+2.08 (+0.33%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

12/02/21 H.C. Wainwright
H.C. Wainwright says Arbutus patent win may mean 'considerable gain' for Roivant
11/28/21 Piper Sandler
Moderna has multiple booster candidates to combat omicron, says Piper Sandler
11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
PFE Pfizer
$53.02 /

-1.65 (-3.02%)

11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 JPMorgan
Pfizer price target raised to $53 from $42 at JPMorgan
11/26/21 Citi
Pfizer can deliver novel vaccine within 100 days of sequencing, says Citi
BNTX BioNTech
$333.55 /

-1.09 (-0.33%)

11/29/21 UBS
BioNTech to benefit if concerns about omicron variant increase, says UBS
11/10/21
Fly Intel: Top five analyst upgrades
11/10/21 H.C. Wainwright
H.C. Wainwright upgrades BioNTech to Buy ahead of likely booster approval
11/10/21 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

07:18 Today Cantor Fitzgerald
Corvus Pharmaceuticals price target raised to $8 from $5 at Cantor Fitzgerald
11/29/21 Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
11/22/21 Bryan Garnier
AstraZeneca downgraded to Buy from Conviction Buy at Bryan Garnier
10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

11/29/21 Credit Suisse
Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
MRK Merck
$73.89 /

-0.54 (-0.73%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
LLY Eli Lilly
$247.84 /

-1.39 (-0.56%)

11/30/21 Canaccord
Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/24/21 Truist
Eli Lilly price target raised to $301 from $262 at Truist
11/18/21 BMO Capital
Eli Lilly initiated with an Outperform at BMO Capital
REGN Regeneron
$634.44 /

+2.08 (+0.33%)

12/02/21 JonesTrading
Decibel Therapeutics initiated with a Buy at JonesTrading
11/30/21 H.C. Wainwright
Regeneron should be bought on today's selloff, says H.C. Wainwright
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
MRNA Moderna
$301.46 /

-9.24 (-2.97%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

BNTX BioNTech
$333.55 /

-1.09 (-0.33%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

LLY Eli Lilly
$247.84 /

-1.39 (-0.56%)

REGN Regeneron
$634.44 /

+2.08 (+0.33%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

BNTX BioNTech
$333.55 /

-1.09 (-0.33%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

LLY Eli Lilly
$247.84 /

-1.39 (-0.56%)

REGN Regeneron
$634.44 /

+2.08 (+0.33%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

BNTX BioNTech
$333.55 /

-1.09 (-0.33%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

LLY Eli Lilly
$247.84 /

-1.39 (-0.56%)

REGN Regeneron
$634.44 /

+2.08 (+0.33%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

BNTX BioNTech
$333.55 /

-1.09 (-0.33%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

LLY Eli Lilly
$247.84 /

-1.39 (-0.56%)

REGN Regeneron
$634.44 /

+2.08 (+0.33%)

Recommendations
Sunstone Hotel price target raised to $12 from $11 at Truist » 08:24
12/03/21
12/03
08:24
12/03/21
08:24
SHO

Sunstone Hotel

$11.01 /

+0.53 (+5.06%)

Truist analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHO Sunstone Hotel
$11.01 /

+0.53 (+5.06%)

SHO Sunstone Hotel
$11.01 /

+0.53 (+5.06%)

11/14/21 Evercore ISI
Sunstone Hotel downgraded to In Line from Outperform at Evercore ISI
08/24/21
Fly Intel: Top five analyst upgrades
08/24/21 Wells Fargo
Sunstone Hotel upgraded to Equal Weight after underperformance at Wells Fargo
08/24/21 Wells Fargo
Sunstone Hotel upgraded to Equal Weight from Underweight at Wells Fargo
SHO Sunstone Hotel
$11.01 /

+0.53 (+5.06%)

SHO Sunstone Hotel
$11.01 /

+0.53 (+5.06%)

Recommendations
Playa Hotels & Resorts price target raised to $8 from $7 at Truist » 08:23
12/03/21
12/03
08:23
12/03/21
08:23
PLYA

Playa Hotels & Resorts

$7.29 /

+0.45 (+6.58%)

Truist analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLYA Playa Hotels & Resorts
$7.29 /

+0.45 (+6.58%)

PLYA Playa Hotels & Resorts
$7.29 /

+0.45 (+6.58%)

05/07/21 Deutsche Bank
Playa Hotels & Resorts price target raised to $10 from $8 at Deutsche Bank
04/13/21 BofA
Playa Hotels & Resorts initiated with a Buy at BofA
03/08/21 Deutsche Bank
Playa show see cash flow inflection no later than Q4, says Deutsche Bank
01/11/21 Macquarie
Playa Hotels & Resorts price target raised to $8 from $7 at Macquarie
PLYA Playa Hotels & Resorts
$7.29 /

+0.45 (+6.58%)

  • 09
    Nov
  • 07
    Jan
Recommendations
Park Hotels & Resorts price target raised to $22 from $18 at Truist » 08:23
12/03/21
12/03
08:23
12/03/21
08:23
PK

Park Hotels & Resorts

$16.74 /

+0.75 (+4.69%)

Truist analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PK Park Hotels & Resorts
$16.74 /

+0.75 (+4.69%)

PK Park Hotels & Resorts
$16.74 /

+0.75 (+4.69%)

10/18/21 Wells Fargo
Park Hotels & Resorts downgraded to Equal Weight from Overweight at Wells Fargo
10/18/21 Wells Fargo
Park Hotels & Resorts downgraded to Equal Weight from Overweight at Wells Fargo
08/17/21 Truist
Park Hotels & Resorts upgraded to Hold from Sell at Truist
08/17/21 Truist
Park Hotels & Resorts upgraded to Hold from Sell at Truist
PK Park Hotels & Resorts
$16.74 /

+0.75 (+4.69%)

PK Park Hotels & Resorts
$16.74 /

+0.75 (+4.69%)

Recommendations
Host Hotels price target raised to $18 from $16 at Truist » 08:23
12/03/21
12/03
08:23
12/03/21
08:23
HST

Host Hotels

$15.80 /

+0.43 (+2.80%)

Truist analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HST Host Hotels
$15.80 /

+0.43 (+2.80%)

HST Host Hotels
$15.80 /

+0.43 (+2.80%)

11/09/21 Compass Point
Host Hotels upgraded to Buy at Compass Point amid hotel sector rebound
11/09/21 Compass Point
Host Hotels upgraded to Buy from Neutral at Compass Point
10/18/21 Wells Fargo
Host Hotels upgraded to Equal Weight from Underweight at Wells Fargo
10/18/21 Wells Fargo
Host Hotels upgraded to Equal Weight from Underweight at Wells Fargo
HST Host Hotels
$15.80 /

+0.43 (+2.80%)

HST Host Hotels
$15.80 /

+0.43 (+2.80%)

HST Host Hotels
$15.80 /

+0.43 (+2.80%)

Recommendations
Hyatt price target raised to $78 from $76 at Truist » 08:22
12/03/21
12/03
08:22
12/03/21
08:22
H

Hyatt

$83.27 /

+5.45 (+7.00%)

Truist analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
H Hyatt
$83.27 /

+5.45 (+7.00%)

H Hyatt
$83.27 /

+5.45 (+7.00%)

12/02/21 Loop Capital
Hyatt upgraded to Buy from Hold at Loop Capital
11/29/21
Fly Intel: Top five analyst upgrades
11/29/21 JPMorgan
Hyatt upgraded to Overweight from Neutral at JPMorgan
11/17/21
Fly Intel: Top five analyst upgrades
H Hyatt
$83.27 /

+5.45 (+7.00%)

  • 23
    Sep
H Hyatt
$83.27 /

+5.45 (+7.00%)

H Hyatt
$83.27 /

+5.45 (+7.00%)

Recommendations
Choice Hotels price target raised to $125 from $114 at Truist » 08:22
12/03/21
12/03
08:22
12/03/21
08:22
CHH

Choice Hotels

$145.68 /

+5.685 (+4.06%)

Truist analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHH Choice Hotels
$145.68 /

+5.685 (+4.06%)

CHH Choice Hotels
$145.68 /

+5.685 (+4.06%)

12/02/21
Fly Intel: Top five analyst downgrades
12/02/21 Loop Capital
Choice Hotels downgraded to Hold from Buy at Loop Capital
11/17/21
Fly Intel: Top five analyst downgrades
11/17/21 Wells Fargo
Wells Fargo upgrades Hyatt to Overweight, raises price target to $96
CHH Choice Hotels
$145.68 /

+5.685 (+4.06%)

Upgrade
Ryman Hospitality upgraded to Hold from Sell at Truist » 08:17
12/03/21
12/03
08:17
12/03/21
08:17
RHP

Ryman Hospitality

$77.93 /

+3.365 (+4.51%)

Truist analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHP Ryman Hospitality
$77.93 /

+3.365 (+4.51%)

RHP Ryman Hospitality
$77.93 /

+3.365 (+4.51%)

07:39 Today Truist
Ryman Hospitality upgraded to Buy from Hold at Truist
11/03/21 Deutsche Bank
Ryman Hospitality price target raised to $106 from $95 at Deutsche Bank
08/05/21 Deutsche Bank
Ryman Hospitality price target raised to $95 from $88 at Deutsche Bank
07/12/21 Raymond James
Ryman Hospitality upgraded to Outperform from Market Perform at Raymond James
RHP Ryman Hospitality
$77.93 /

+3.365 (+4.51%)

Recommendations
Ulta Beauty price target raised to $400 from $390 at Jefferies » 08:16
12/03/21
12/03
08:16
12/03/21
08:16
ULTA

Ulta Beauty

$383.13 /

+12.8 (+3.46%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

08:09 Today BMO Capital
Ulta Beauty price target raised to $365 from $345 at BMO Capital
07:54 Today Credit Suisse
Ulta Beauty price target raised to $455 from $415 at Credit Suisse
07:46 Today Raymond James
Ulta Beauty price target raised to $485 from $460 at Raymond James
07:39 Today Stifel
Ulta Beauty price target raised to $435 from $400 at Stifel
ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

Hot Stocks
Encompass Health to build inpatient rehabilitation hospital in Amarillo, Texas » 08:12
12/03/21
12/03
08:12
12/03/21
08:12
EHC

Encompass Health

$58.39 /

+1.81 (+3.20%)

Encompass Health…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EHC Encompass Health
$58.39 /

+1.81 (+3.20%)

EHC Encompass Health
$58.39 /

+1.81 (+3.20%)

11/03/21 Mizuho
Encompass Health price target lowered to $80 from $94 at Mizuho
11/01/21 BMO Capital
Encompass Health price target lowered to $75 from $102 at BMO Capital
10/29/21 Deutsche Bank
Encompass Health price target lowered to $95 from $110 at Deutsche Bank
10/13/21 Truist
Encompass Health price target lowered to $88 from $100 at Truist
EHC Encompass Health
$58.39 /

+1.81 (+3.20%)

EHC Encompass Health
$58.39 /

+1.81 (+3.20%)

EHC Encompass Health
$58.39 /

+1.81 (+3.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.